Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Ralinepag

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1187856-49-0, Apd-811, Apd811, Cqy12zjn6e, Chembl3919269, 2-((trans-4-((((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetic acid
    Molecular Formula
    C23H26ClNO5
    Molecular Weight
    431.9  g/mol
    InChI Key
    NPDKXVKJRHPDQT-UHFFFAOYSA-N
    FDA UNII
    CQY12ZJN6E
    Ralinepag has been used in trials studying the treatment of Pulmonary Arterial Hypertension.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[[4-[[(4-chlorophenyl)-phenylcarbamoyl]oxymethyl]cyclohexyl]methoxy]acetic acid
    2.1.2 InChI
    InChI=1S/C23H26ClNO5/c24-19-10-12-21(13-11-19)25(20-4-2-1-3-5-20)23(28)30-15-18-8-6-17(7-9-18)14-29-16-22(26)27/h1-5,10-13,17-18H,6-9,14-16H2,(H,26,27)
    2.1.3 InChI Key
    NPDKXVKJRHPDQT-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    C1CC(CCC1COCC(=O)O)COC(=O)N(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
    2.2 Other Identifiers
    2.2.1 UNII
    CQY12ZJN6E
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 2-((4-(((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate

    2.3.2 Depositor-Supplied Synonyms

    1. 1187856-49-0

    2. Apd-811

    3. Apd811

    4. Cqy12zjn6e

    5. Chembl3919269

    6. 2-((trans-4-((((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetic Acid

    7. 2-[[4-[[(4-chlorophenyl)-phenylcarbamoyl]oxymethyl]cyclohexyl]methoxy]acetic Acid

    8. Acetic Acid, 2-((trans-4-(((((4-chlorophenyl)phenylamino)carbonyl)oxy)methyl)cyclohexyl)methoxy)-

    9. Ralinepag [usan:inn]

    10. Unii-cqy12zjn6e

    11. Ralinepag [usan]

    12. Ralinepag [inn]

    13. Ralinepag (usan/inn)

    14. Ralinepag [who-dd]

    15. Schembl1118504

    16. Schembl1118506

    17. Chembl3301604

    18. Schembl12786473

    19. Schembl21232597

    20. Apd 811

    21. Bcp30843

    22. Bdbm50235385

    23. Bdbm50235386

    24. Db12462

    25. Sb16964

    26. Hy-16751

    27. Apd-811; Apd 811; Apd811

    28. Cs-0012350

    29. J3.614.088g

    30. D10725

    31. P14968

    32. An-584/43522715

    33. Q27275655

    34. ({4-[({[4-chloro(phenyl)anilino]carbonyl}oxy)methyl]cyclohexyl}methoxy)acetic Acid

    35. 2-(((1r,4r)-4-((phenyl(p-tolyl)carbamoyloxy)methyl)cyclohexyl)methoxy) Acetic Acid

    36. 2-(((1r,4r)-4-((((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetic Acid

    2.4 Create Date
    2009-10-07
    3 Chemical and Physical Properties
    Molecular Weight 431.9 g/mol
    Molecular Formula C23H26ClNO5
    XLogP35
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count9
    Exact Mass431.1499506 g/mol
    Monoisotopic Mass431.1499506 g/mol
    Topological Polar Surface Area76.1 Ų
    Heavy Atom Count30
    Formal Charge0
    Complexity538
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of pulmonary arterial hypertension